Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

iL-PRF treatment improves hair growth for androgenetic alopecia.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Permanent hair dye mixtures can irritate and damage the skin.

IL-36α helps grow new hair follicles and speeds up wound healing.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

CGF therapy may effectively treat psoriasis by reducing inflammation.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

1,25-(OH)2D3 helps hair grow by blocking certain harmful signals.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.